Nitazoxanide (brand name: Alinia™)
A broad‑spectrum antiparasitic and antiviral agent primarily used to treat protozoal and helminthic infections in children and adults. Below is a concise, evidence‑based overview—feel free to ask follow‑up questions if you need more detail!
1. What Is Nitazoxanide?
| Feature |
Details |
| Drug class |
Thiazolide derivative, an oxazole‑based anti‑parasitic/antiviral |
| Approved indications |
• Giardia lamblia (giardiasis) in children ≥3 mo and adults.
• Cryptosporidium parvum (cryptosporidiosis) in immunocompetent hosts.
• Entamoeba histolytica (amoebiasis) in children and adults.
• Clostridioides difficile (C. difficile) diarrhea (in some jurisdictions). |
| Mechanism of action |
Inhibits the pyruvate‑ferrodoxin oxidoreductase (PFOR) enzyme, crucial for anaerobic energy metabolism of parasites and some viruses. Also interferes with host cell metabolic pathways. |
2. How Is It Taken?
| Population |
Typical dose |
Duration |
| Adults & children ≥ 6 y |
250 mg orally twice daily (total 500 mg/day) |
5 days (Giardia, cryptosporidium, amoebiasis); 10 days (C. difficile) |
| Children 3–6 y |
250 mg twice daily (or 125 mg twice daily for 5 days if weight < 20 kg) |
5 days |
| Children < 3 mo |
Not recommended (insufficient data) |
| Pregnancy & lactation |
Use only if clearly needed; data limited but generally considered low‑risk. |
- Administration tips
- Can be taken with or without food.
- If taken with high‑fat meals, absorption increases slightly but the drug is still effective.
- Do not crush or chew the tablets; swallow whole.
3. Common Side Effects
| System |
Typical adverse events |
Frequency (≈ ≤ 10 %) |
| GI |
Nausea, abdominal pain, mild diarrhea |
5–8 % |
| CNS |
Headache, dizziness |
3–5 % |
| General |
Rash, pruritus |
< 2 % |
| Hepatic |
Rare elevation of transaminases (monitor if symptomatic) |
< 1 % |
Most patients tolerate the drug well; serious adverse reactions are uncommon.
4. Contraindications & Precautions
| Contraindicated? |
Explanation |
| Known hypersensitivity to nitazoxanide or thiazoles |
Avoid; severe allergic reactions may occur. |
| Severe hepatic impairment |
Metabolized hepatically; monitor liver function. |
| Pregnancy (Category B) |
Limited data; risk–benefit assessment required. |
| Lactation |
Low transfer to breast milk; still use cautiously. |
| Immunocompromised hosts (HIV, transplant) |
Use with caution; efficacy against cryptosporidium is lower. |
Drug interactions:
- Minimal clinically relevant interactions due to low protein binding.
- CYP3A4 inhibitors/inducers may slightly alter plasma levels but generally not a major concern.
- Concurrent use with antacids: no significant effect.
5. Special Populations
| Group |
Key points |
| Pregnancy |
Category B (no evidence of fetal harm in humans), but data are limited. Use only if benefits outweigh risks. |
| Breastfeeding |
Low concentration in breast milk; still avoid if possible unless benefits justify. |
| Children |
Approved for ages ≥ 3 mo. Dosing is weight‑based; careful monitoring for side effects. |
| Renal impairment |
Not cleared significantly by kidneys; no dose adjustment needed. |
| Elderly |
Standard dosing; monitor for GI upset. |
6. How Does Nitazoxanide Work Against Viruses?
Nitazoxanide shows antiviral activity against a variety of viruses (e.g., rotavirus, norovirus, influenza A/B, hepatitis C) in vitro and in early clinical trials, but it’s not approved as a general antiviral therapy. Its role remains investigational and mainly supportive for gastrointestinal viral pathogens.
7. Quick Reference: “What If” Scenarios
| Scenario |
Recommendation |
| Patient missed a dose |
Take as soon as remembered; skip the next dose to avoid double‑dosing. |
| Persistent diarrhea after finishing therapy |
Re‑evaluate for resistant organisms or other causes; consider a second course or alternative therapy. |
| Severe rash or swelling |
Stop medication immediately and seek medical attention. |
| Pregnancy discovered during treatment |
Discuss with healthcare provider; may need to continue if infection is severe, but weigh risks. |
8. Where to Get More Information
- FDA label (Alinia®) – for the most up‑to‑date prescribing info.
- CDC – Giardia, Cryptosporidium, Amoebiasis treatment guidelines.
- ClinicalTrials.gov – ongoing studies on nitazoxanide’s antiviral effects.
Bottom Line
Nitazoxanide (Alinia™) is a safe, orally administered agent that effectively treats a range of protozoal infections and has promising antiviral potential. It’s typically well tolerated, requires no routine laboratory monitoring, and can be used safely in children and adults when indicated. If you’re considering it for yourself or a loved one, discuss with your healthcare provider to confirm the diagnosis, confirm dosing, and rule out contraindications.